Webinars and Commercial Conversations — Register Now

Tuesday, December 1, 2026, 1 PM-2 PM ET

Join UCSF clinical microbiologists as they share their journey from using multiple respiratory testing platforms to implementing a flexible, stewardship-driven testing strategy. Learn how customizable respiratory panels helped streamline workflows, improve efficiency, and better align testing with patient needs.

Webinar presenters Danielle Ingebrigtsen, MHS, Clinical Laboratory Scientist Supervisor, UCSF Health, and Rama Yakubu, MD, PhD, Assistant Professor of Laboratory Medicine, Co-Director of Microbiology, UCSF Health.

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diasorin.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, December 9, 2026, 12 PM-1 PM ET
Hear an expert pathologist discuss the role of HER2 IHC testing and scoring in solid tumors including endometrial, ovarian, cervical, bladder, non-small cell lung, colorectal, and biliary cancers

Webinar presenter Michelle Shiller, DO, MSPT, Baylor Sammons Cancer Center; Fulgent Genetics; Texas Cancer Interception Institute

CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, January 12, 2027, 2 PM-3 PM ET
Hear Dr. Roden discuss how computational pathology will impact the practice & future of precision oncology, using global real world analytical evidence for the novel TROP2 NMR biomarker as an example.

Webinar presenter Anja C. Roden, MD, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Professor of Laboratory Medicine and Pathology
Mayo Clinic College of Medicine and Science, Rochester, Minnesota

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Roche Diagnostics. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Manage Subscription

To receive CAP TODAY magazine, please subscribe here.
For change of address, mail new information to: CAP TODAY Circulation, 325 Waukegan Road, Northfield, IL 60093-2750 or visit here.

Commercial Conversations

Beyond histology: TissueCypher for Barrett’s esophagus

November 2026—This conversation is part of a series of one-on-one virtual roundtables in which CAP TODAY publisher Bob McGonnagle speaks with one vendor and one laboratory expert to spotlight a company and a customer for their laboratory solutions and work. He spoke on Aug. 6 with Emmanuel Gorospe, MD, MPH, GI medical director for Castle Biosciences, and Daniel Jondle, MD, gastrointestinal pathologist and director of the Arizona Digestive Health pathology laboratory. Dr. Jondle is a paid speaker of Castle and was compensated for his participation in this roundtable session.

Blood collection tubes: Do you know what they’ve been tested for?

October 2026—This conversation is part of a series of one-on-one virtual roundtables in which CAP TODAY publisher Bob McGonnagle speaks with representatives of a company to spotlight its laboratory solutions. He spoke on July 21 with Nick Fingland, PhD, PMP, senior director of R&D operations and science, BD, and Chris Farnsworth, PhD, D(ABCC), section head of clinical chemistry, WashU Medicine, and professor of pathology and immunology and of emergency medicine, Washington University. McGonnagle’s questions and their answers follow. The title of their talk: Where quality begins: the real impact of blood collection choices.

Watch the full conversation:

This roundtable discussion is sponsored by BD.

Why Speed Matters: The Expanding Role of Rapid NGS in Precision Oncology

October 2026—This discussion is part of a series of one-on-one virtual roundtables in which CAP TODAY publisher Bob McGonnagle speaks with vendors and laboratory experts to spotlight a company and a customer for their laboratory solutions and work. He spoke on September 30, 2026 with John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, Flora Berisha, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson, Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering, Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering, Cancer Center.

Watch the full conversation:

This roundtable discussion is sponsored by Pillar Biosciences.

Assessment of HbA1c in Patients with Hemoglobin Variants

September 2026—This discussion is part of a series of one-on-one virtual roundtables in which CAP TODAY publisher Bob McGonnagle speaks with one vendor and one laboratory expert to spotlight a company and a customer for their laboratory solutions and work. He spoke on September 23, 2026 with David Sacks MB, ChB, FRCPath, Chairman, Steering Committee, National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience Inc.

Dr. Sacks
Sivaraman

Watch the full conversation:

This roundtable discussion is sponsored by TOSOH.

The TissueCipher test for risk stratification in Barrett’s esophagus

In this commercial conversation, Bob McGonnagle, CAP TODAY publisher, speaks with Dr. Daniel Jondle, a fellowship-trained GI pathologist and director of the Arizona Digestive Health Pathology Laboratory (GI Alliance and Specialty Alliance), and Dr. Emmanuel Garaspe is a board-certified gastroenterologist and GI medical director at Castle Biosciences. Originally broadcast on August 6, 2026, this commercial conversation is made possible by a special educational grant from Castle Biosciences.

In support of infectious disease diagnostics and public health

June 2026—CAP TODAY publisher Bob McGonnagle spoke on March 12 with Jessica Van Allen, PhD, technical support lead for ZeptoMetrix, and Jesse M. Young, PhD, medical director for TriCore Research Institute’s research and clinical trials department and director of point-of-care testing. Dr. Young is also clinical assistant professor at the University of New Mexico.

Dr. Young
Dr. Van Allen

Read the article:

Bob McGonnagle: Dr. Young, tell us about TriCore and the laboratories you oversee.

Dr. Young (TriCore): TriCore Reference Laboratory is a full-service diagnostic laboratory. The core laboratory offers about 2,900 test codes and has a modality similar to that of Labcorp and Quest, but we’re focused on New Mexican populations. We serve most of the hospitals in the area and have statewide collection sites whereby we’re trying to expand health care and provide coverage for our communities so everyone in the state has access to health care near their home instead of having to drive six hours to the nearest collection site, drive home, and then be called back for a critical value. Continue reading …

Watch the full conversation:

This roundtable discussion is sponsored by ZeptoMetrix.

Speed, scale, and simplicity in microarray analyzer

April 2026—CAP TODAY publisher Bob McGonnagle spoke on Feb. 19 with Thermo Fisher Scientific’s Ravi Gupta, MBA, VP and general manager; Robert Balog, PhD, MBA, senior director, research and development; and Poulomi Acharya, PhD, senior director, global product management and market development, genetic sciences.

Ravi Gupta
Gupta
Robert Balog
Dr. Balog

Read the article:

Bob McGonnagle: Thermo Fisher launched last fall the SwiftArrayStudio, a next-generation microarray analyzer that will support genomics research and clinical applications through the use of laboratory-validated and -developed tests. Ravi Gupta, what motivated the development of this analyzer?

Ravi Gupta: The SwiftArrayStudio resulted from listening to customers. It addresses the scientific and operational pressures observed in modern genomics. I call them the real-world needs. For decades, labs across human predictive genomics and agrigenomics have dealt with persistent challenges in workflow complexity, inconsistent turnaround times, and escalating costs. Continue reading …

Watch the full conversation:

This roundtable discussion is sponsored by Thermo Fisher Scientific.

Developing novel assays for disease states

February 2026—CAP TODAY publisher Bob McGonnagle spoke on Dec. 2, 2025 with Steve Swartzell and Scott Johnston of ELITechGroup. McGonnagle’s questions and their answers follow. A few of the questions came from the roundtable audience and are identified as such.

Scott Johnston
Johnston
Steven Swartzell
Swartzell

Read the article:

Bob McGonnagle: Steve, how long have you been with ELITech and what is your background in molecular diagnostics?

Steve Swartzell: I am director of customer experience and have been with ELITechGroup for 22 years. My background is in microbiology. I started as a research scientist in R&D and I was an application specialist working directly with customers. I have many years of lab experience as well. Now I oversee all the field activities for ELITechGroup MDx in the U.S. Continue reading …

Watch the full conversation:

This roundtable discussion is sponsored by ELITechGroup.

Payers, policies, and claims processing

November 2025—CAP TODAY publisher Bob McGonnagle spoke on Oct. 1, 2025 with Sarah Stewart of Telcor, which sells laboratory revenue cycle management software and services, and Jeanette Gray and Scott Rupnow of Pathology Associates of San Antonio and Pathology Reference Laboratory.

Scott Rupnow
Rupnow
Sarah Stewart
Stewart
Jeanette Gray
Gray

Read the article:

Bob McGonnagle: Jeanette Gray, tell us about your laboratory.

Jeanette Gray, vice president of revenue and payer relations, Pathology Associates of San Antonio and Pathology Reference Laboratory: We are a physician-owned practice in San Antonio and we operate a laboratory that does primarily anatomic pathology and women’s health testing. We have about 20-plus pathologists on staff. I joined the practice in July. Continue reading …

Watch the full conversation:

This roundtable discussion is sponsored by Telcor.

External controls critical to crucial assays

August 2025—CAP TODAY publisher Bob McGonnagle spoke on May 14 with Jessica Van Allen, PhD, technical support lead for ZeptoMetrix, and Meghan Starolis, MS, PhD, HCLD(ABB), senior science director for infectious diseases at Quest Diagnostics, Chantilly, Va.

Jessica VanAllen
Dr. Van Allen
Dr. Starolis
Dr. Starolis

Read the article:

Bob McGonnagle: Jessica Van Allen, I’d like to talk about some of the hot topics in molecular infectious disease testing, and you mentioned in our discussions offline that viral load testing for transplant viruses is becoming ever more important in the field. Can you make a few remarks about that?

Jessica Van Allen, PhD (Zepto­Metrix): There’s testing that is done using laboratory-developed tests and testing performed using FDA-cleared assays. Those are the two big buckets of testing in the labs of our customers. Meghan and I attended a conference recently at which a couple of the speakers talked about viral load testing for common transplant viruses—EBV, CMV, VZV, some adenoviruses. We’ve been playing in that field for a long time in terms of molecular controls for viruses, so they’re products we’ve had on the shelf. Continue reading …

Watch the full conversation:

This roundtable discussion is sponsored by ZeptoMetrix.